ONGA
OSCR icon

O'Neil Global Advisors’s Oscar Health OSCR Stock Holding History

O'Neil Global Advisors’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-76,326
Closed -$615K – 88
2023
Q2 		$615K Buy
+76,326
New +$563K 0.13% 49

Other funds holding OSCR

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

O'Neil Global Advisors's OSCR Position: Q3 2023 in Review

O'Neil Global Advisors sold out of Oscar Health (OSCR) in Q3 2023, closing a stake of 76,326 shares — an estimated $615K sold.

O'Neil Global Advisors first reported a position in OSCR in Q2 2023 and held it in 1 quarter. The position peaked at $615K in Q2 2023. 177 funds tracked by Wall St. Rank hold OSCR as of Q3 2023.

  • O'Neil Global Advisors reported no remaining Oscar Health position as of Q3 2023 after selling out during the quarter.
  • O'Neil Global Advisors sold 76,326 Oscar Health shares in Q3 2023, an estimated $615K.
  • O'Neil Global Advisors first reported a position in Oscar Health in Q2 2023 and held it in 1 quarter.
  • O'Neil Global Advisors's Oscar Health position peaked at $615K in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Oscar Health as of Q3 2023.

Based on O'Neil Global Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.